Clinical Trial Update: A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

View source ↗

Summary

The post-approval LAP-BAND LBMI study for obesity/overweight has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LAP-BAND

Snippet

Sponsor: Apollo Endosurgery, Inc. | Conditions: Obesity, Overweight | Status: TERMINATED